Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Dapagliflozin 10mg Tab
Locations
1
China
Jinling Hospital
Nanjing, Jiangsu, China
Start Date
November 15, 2023
Primary Completion Date
June 30, 2026
Completion Date
September 30, 2026
Last Updated
September 5, 2024
NCT06499948
NCT06065852
NCT04947813
NCT00481130
NCT02136862
NCT00622544
Lead Sponsor
Nanjing University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions